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ABSTRACT Cancer is the second leading cause of death
globally after cardiovascular disease. Long-term cancer
survival has improved in the Western world due to early
detection and the use of effective combined treatment
modalities, as well as the development of effective
immunotherapy and drug-targeted therapy. Surgery is still
the mainstay for most solid tumors; however, low- and
middle-income countries are facing an increasing lack of
primary surgical care for easily treatable conditions,
including breast, colon, and head and neck cancers. In this
paper, a surgical oncology view is presented to elaborate
how the Western surgical oncologist can take part in the
‘surgical fight’ against global disparities in cancer care,
and a plea is made to strive for structural solutions, such as
a partnership in surgical oncology training. The pros and
cons of the use of eHealth and mHealth technologies and
education programs for schools and the community are
discussed as these create an opportunity to reach a large
portion of the population in these countries, at low cost and
with high impact.
Cancer is the only disease which is steadily upon to increase worldwide
Roswell Park, 1899.
Global disparities in healthcare arise from a complex
interplay of economic, educational, social, and cultural
factors. At the Lancet Commission on Global Surgery 2030
meeting on 17 January 2014 in Boston, Jim King, President
of the World Bank, stated that ‘‘surgery is an indivisible,
indispensable part of healthcare and can help millions of
people lead healthier, more productive lives.’’ In 2015, The
Lancet Commission published an extensive report with
evidence and solutions for achieving health, welfare, and
economic development,1 while another report was pub-
lished in regard to the delivery of safe, affordable, and
timely cancer surgery.2 These two extensive papers were
discussed shortly afterwards in editorials in Annals of
Surgical Oncology and the European Journal of Surgical
Oncology.2,3
Since 2013, cancer has been the second leading cause of
death globally after cardiovascular disease, and is expected
to increase in all countries due to population growth, aging,
and increasing prevalence of risk factors.4 An estimated
20 % of ‘global surgery’ has been denoted as ‘cancer
surgery’. In high-income countries (HICs), the standards of
evidence-based multimodality cancer treatment (surgery,
radiation, and systemic treatment) have been well defined,
whereas the standards of surgical and anesthesia care in
low- and middle-income countries (LMICs) are stagnating
or regressing.1 This disparity in cancer care requires an
accurate analysis to improve overall (surgical) cancer
care.5
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In this paper, the difference between cancer surgery,
training, and quality assurance in HICs, and the common
lack of such provisions in LMICs, are addressed. The
potential role of community- and university-based surgical
oncologists and surgical oncology societies in fighting the
global disparity in cancer care is discussed. Finally, sug-
gestions are made as to the use of new electronic
technologies in teaching healthcare workers in LMICs and
creating a general awareness of (malignant) diseases with
lifestyle risk factors.
THE EVOLUTION OF CANCER SURGERY,
TRAINING, AND QUALITY ASSURANCE
In most Western countries, long-term survival has
doubled for some cancers, such as breast and colon cancer,
over the past 40 years through early detection, the use of
effective combined treatment modalities, radiation, and/or
systemic treatment, reducing the 30-day postoperative
mortality due to improved surgical techniques, surgical
equipment with less intraoperative and postoperative
bleeding, and, last but not least, anesthesia and intensive
care facilities. Today, personalized cancer surgery has
become a reality with the conservation of the integrity and
function of the body and the preservation of quality of life.
Compared with LMICs, surgeons in HICs have the ability
to stage cancer patients using computed tomography (CT),
magnetic resonance imaging (MRI), positron emission
tomography (PET), and/or sentinel lymph node biopsy
(SLNB), and to use effective combined treatment modali-
ties with the various radiation techniques, treatment
planning, radiation doses, and systemic approaches ranging
from hormonal, chemotherapy, and immunotherapy to
targeted drug therapy, as well as the various surgical
interventions, from conventional surgery and laparoscopic
procedures to robotic and image-guided surgery. For many
types of cancer, surgery has plateaued as a treatment in
regard to morbidity and mortality, local control, and long-
term survival, whereas, in palliative care, the role of sur-
gery is explored continuously. New developments are still
being made in minimally invasive surgery, such as single-
incision laparoscopic surgery, robot-assisted laparoscopic
surgery, transanal endoscopic microsurgery, and natural
orifice transluminal endoscopic surgery.6 All these proce-
dures are accompanied by steep learning curves and require
centralization of the surgical care of these cancer patients.
There is significant diversity in surgical (oncology)
training programs and certification requirements, with an
inverse correlation to a country’s income. Almost all HIC
and LMIC surgical (sub)specializations are organ-based
rather than focused on oncology, with significant vari-
ability in the training of surgical oncologists worldwide.7
Although today most LMICs do not have these structured
surgical oncology training pathways, at the same time, a few
LMICs have had structured surgical oncology fellowships in
place for a number of decades now. In HICs, surgeons have
taken the lead with regard to further specializing in cancer
surgery at high-volume centers, with centralization of cancer
surgery in accredited cancer centers.
Thirty-five national surgical oncology societies cur-
rently comprise the World Federation of Surgical
Oncology Societies (WFSOS), but no international, equally
acknowledged surgical oncology curriculum exists.8 The
Society of Surgical Oncology (SSO) and European Society
of Surgical Oncology (ESSO) have well-defined surgical
oncology curricula and, in Mexico, a program with certi-
fication was recently started under the auspices of the
Consejo Mexicano de Oncologı´a (CMO).9–11 Training
programs are also running in other LMICs, but a great
diversity exists globally, and training and certification
should therefore be streamlined.7 In Europe, the Union
Europe´enne des Me´decins Spe´cialiste (UEMS) represents
more than 50 medical disciplines in 34 countries, and the
Division of Surgical Oncology was established in 2003 to
promote excellence in cancer surgery across Europe, along
with European board examinations and certifications.12
Board certification for cancer surgery was introduced in the
USA and The Netherlands in 2011 and 2014,
respectively.13,14
These board certifications and quality assurance pro-
grams improved the surgical oncology outcome in HICs,
but LMICs still face the burden and need for more surgical
care. The incidence of cancer has increased tremendously
in LMICs, leading to a growing discrepancy between the
demands and opportunities of surgical care. Too few sur-
geons are trained in basic surgical oncological
procedures.15
BURDEN OF SURGICAL CANCER CARE
Advances in (cancer) surgery have been ignored in
LMICs. Well-equipped hospitals are present in most cap-
itals of LMICs, but a majority of the surgeons work with
limited resources and a majority of their cancer patients are
diagnosed at an advanced stage, with limited opportunities
for effective cancer treatment. Even if patients in LMICs
are treated, they are at high risk of recurrence and disease-
related morbidity and mortality. The financial condition of
each patient and financial support from family are gener-
ally limited as adequate health insurance is obsolete and
bureaucratic. With the exception of the big cities, limited
advanced diagnostic radiology capabilities are available in
LMICs and, in general, there is a lack of (updated) radia-
tion facilities. Furthermore, the Lancet Oncology
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Commission suggests that investment in and expansion of
global access to radiotherapy could save lives and may
have positive economic benefits; however, first and fore-
most, this requires billions of dollars of investments.
Second, it also requires education and licensing programs
for LMIC physicians specializing in radiation oncology at
foreign cancer institutions in HICs.16 Systemic cancer
treatment has been inhibited by the lack of well-equipped
pharmacies, and effective chemotherapy protocols with
targeted therapy are generally not affordable. Complica-
tions associated with systemic treatment may add to the
burden of care due to the lack of effective antibiotics and/
or injectable growth factors. The opportunities that most
HIC surgeons have for maintaining the integrity of the
patient’s body are not available in LMICs, especially when
the patients have advanced cancer. The gap between the
healthcare system in HICs and LMICs is not expected to
close soon.
Because surgeons are the primary caregivers for cancer
in LMICs, competent surgeons should be trained in a
shorter period of time to become ‘basic surgical oncolo-
gists’ for the most commonly diagnosed cancers. This
training should also include the basic principles of systemic
anticancer treatment, as well as palliative care. How can
Western surgeons and (surgical) oncologists play a major
role in addressing and tackling the burden of surgical
cancer care with disproportionate increases in that burden
in LMICs? To achieve this role there are, among others,
some important conditions to be fulfilled: (i) acknowledge
the global surgical oncology disease burden; (ii) commence
a global movement through the World Health Organization
(WHO), making efficient use of the International Agency
for Research on Cancer (IARC) programs, the US National
Cancer Institute Center for Global Health, the Lancet
Global Surgery Commission, and global cancer consor-
tiums (GCC); (iii) train surgeons to be surgical oncologists
through partnership programs with foreign institutions and/
or through collaboration with international (surgical) can-
cer society programs focusing on LMICs, or through
Comprehensive Cancer Centers; and (iv) HICs can be
involved in cancer research in LMICs.5,17–20 Qualitative
and quantitative research should be encouraged in LMICs
to support decision making and patient access to healthcare
facilities, or to obtain data to make policy makers in
LMICs aware of the effects of the collaborations.21
Implementation of these points is an important starting
point to provide a structural solution to the anticipated lack
of knowledge and practical capabilities in LMICs, rather
than the present practice of Western surgeons temporarily
providing voluntary support to surgical clinics individually
or through welfare organizations. The goal should be to
create a situation in LMICs, as summarized in the
following proverb: ‘‘Give a man a fish and you feed him for
a day; teach a man to fish and you feed him for a lifetime.’’
OPPORTUNITIES FOR EDUCATION THROUGH
COLLABORATION
The WHO has just launched the Global Cancer Country
Profiles, which include reference data on cancer mortality
and incidence, risk factors, availability of cancer country
plans, monitoring and surveillance, primary prevention
policies, screening, treatment, and palliative care.22 Pro-
grams are related to cancer control, prevention, early
detection, and palliative care. National smoking bans and
programs promoting obesity rate reduction through life-
style changes will have a dramatic effect on decreasing the
incidence of cancer, cardiovascular diseases, and type II
diabetes in HICs and LMICs. More than 168 countries have
signed the WHO Framework Convention on Tobacco
Control.23 In The Netherlands, for example, an initiative
has been launched by physicians and healthcare entrepre-
neurs to legislate a ban on tobacco purchase and use by any
individual born from 2016 onwards. Even smokers agree
with this ban for their future children. The WHO also has a
global nutrition program with the implementation of the
Global database on the Implementation of Nutrition Action
(GINA).24 In both programs, HICs can support LMICs in
achieving the goals of national campaigns to reduce
smoking and decrease the overweight population. The
Western world can support these campaigns with the
development of specific social media campaigns (see the
eHealth and mHealth section).
In a recent paper, Brennan discussed the possibility of
sophisticated third-year clinical rotation fellowships within
a community cancer program for residents from LMICs.5
Regular postgraduate (surgical) cancer courses in LMICs
will eventually have an impact on the provision of
healthcare. Surgical oncologists or their institution may
adopt the program or collaborate with an overseas uni-
versity or regional hospital and start, through a
memorandum of understanding, a collaborative clinical
surgical oncology/research initiative. Over several decades,
more than 20 Indonesian surgeons, with the support of the
Department of Surgery of the University Medical Center
Groningen (UMCG) and Dutch Cancer Society, received
specific training in the basic principles of surgical (onco-
logic) procedures and palliative care at the Department of
Surgical Oncology, Department of Urology, Department of
Neurosurgery, and Department of Plastic Surgery of the
UMCG. Some received board certifications prior to their
return to Indonesia, but they all later became surgical
(oncology) leaders in Indonesia and distributed their
knowledge through their institutional surgical training
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programs and surgical societies (e.g. oncology societies
such as Perhimpunan Ahli Bedah Onkologi Indonesia;
PERABOI, the Indonesian Society of Surgical Oncology).
Recently, a similar residents training program was initiated
between the Department of Surgery of the UMCG and the
Department of Surgery of the University Hospital Para-
maribo in Suriname. This UMCG training program can
easily be copied by other institutions. Another possibility is
to start a foundation with the goal of improving (surgical)
cancer care in a hospital, region, country, or continent.25
What are the opportunities for the two largest surgical
oncology societies in the fight against cancer, nationally
and globally?9,10 The SSO has 2721 members (52 members
in LMICs, 2 %) and publishes the Annals of Surgical
Oncology (impact factor [IF] 3.943), while the ESSO has
3822 members (49 members in LMICs, 1 %) and publishes
the European Journal of Surgical Oncology (IF 3.009).
Both societies have reduced their fees for membership and
annual meetings for participants from LMICs. Why are
they still unable to grant free electronic subscriptions for
their journals to surgeons, residents, and medical students
in LMICs? This is the way both societies could support our
current and future colleagues in LMICs as the time of
studying from old-fashioned textbooks is over.
eHEALTH and mHEALTH
An important instrument for collaboration through
education is available today, and there is an opportunity to
use modern electronic technology in teaching medical
students, physicians, specialists, healthcare workers, and
nurses, as well as in providing healthcare. eHealth is the
application of information and communication technology
in the service of health. Mobile health (mHealth) is the
practice of medicine and public health supported by mobile
devices. The boost from high-speed internet on smart-
phones and tablets has contributed to the rapid
development of eHealth and mHealth technology, such as
Short Message Service (SMS), Multimedia Message Ser-
vice (MMS), telemonitoring, telecoaching, telecare,
teleconsultation, telediagnosis, teleradiology, telesurgery
(robotic surgery), teleconferencing (regionally, nationally,
internationally) and e-consults. Built-in cameras and video
recorders can be used as sensors to measure or track vital
signs, such as heart rate and respiration. Today, we have
great variation in medical tricorders, portable handheld
scanning devices used by consumers, patients, caregivers,
nurses, or physicians to (self)diagnose medical conditions
within percentages, or show and summarize a person’s
health status, and the data can be electronically transferred
to anywhere in the world, even from rural areas. FaceTime
provides the possibility of rapidly exchanging information
between clinicians, such as when facing an urgent intra-
operative problem. For quick communication among staff
members, WhatsApp is available, a multimedia smart-
phone application for patient care and academic
endorsement. There are no boundaries or disparities with
eHealth and mHealth technology.
The implementation of these techniques in LMICs will
not be without difficulties. The application of eHealth
facilities may be distinguished two ways: support of pri-
mary healthcare professionals, including medical students
and residents, or education for people living in rural and
remote areas. Most LMICs currently have an extensive
cellular phone network and availability of Internet tech-
nology, but they are facing the challenge of receiving
continuous high-quality, affordable, and universally
accessible health education. The application of eHealth
facilities for both purposes may be limited through a
variety of problems. In rural and remote areas in certain
parts of the world, these technologies are probably not
working as optimally as predicted. Although technological
problems may have solutions, there are human factors,
such as behavioral changes, system constraints, and privacy
limitations, which may set barriers in efforts to provide
adequate healthcare information and administer care.26 A
recent Cochrane analysis of studies on enhancing the
effects of primary health interventions by mobile phone
applications, such as SMS and MMS, demonstrated that
much is not yet known about the long-term effects or
potential negative consequences, although one study
showed short-term effects of smoking cessation.27 A study
on the effects of a telehealth system in rural and remote
areas of Brazil indicated that most of the professionals
were satisfied and that the system was cost effective and
led to access to specialized healthcare. The main lessons
learned from this study were that the system requires a
broad collaborative network, must be simple, should have
face-to-face components, and should be applied to address
the problems for which there is a high service demand;
however, the long-term effects of the system require further
study.28 In a recent systematic review of the implementa-
tion of mobile communication techniques in Africa, the
conclusion was that these techniques pose a potential to
becoming an important part of the health sector to establish
innovative approaches to the delivery of care. The benefits
have also been highly recommended, but it is clear that the
projects are not a solution to the challenges that health
systems face in many African countries. More evidence-
based research is necessary in the field of mobile com-
munication technique implementation, especially on a
large scale and for a long time.29 The potential of eHealth
and mHealth technology in education towards cancer pre-
vention, diagnosis and treatment, and the (surgical) fight
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against cancer in LMICs, have not been properly
investigated.
PROSPECTS AND SUGGESTIONS
No major changes are foreseen in the current global
disparities in cancer care or global gross domestic products.
Future world population growth will come from the
LMICs, i.e. countries with a high economic vulnerability,
low life expectancy at birth, low per capita income, low
levels of education, and negative effects of urbanization.
These countries will also have a tremendous increase in
cancer burden by a limited healthcare system. In 2030,
70 % of all cancer deaths will occur in LMICs, and there
will be a shift in the distribution of all types of cancer due
to increased cancer incidence rates with non-infectious
etiology via Western lifestyle changes attributable to eco-
nomic development. The ratio of cancer incidence to
mortality is low in HICs (46 %) and high in LMICs
(75 %);30 however, there have been developments that give
us a reason to be optimistic. On 4 February 2015, the
Health Minister of the Republic of Indonesia, Nila Farid
Moeloek, decreed the Commitment to Cancer Management
in Indonesia. One of the commitments was to support
public regulation for prevention via a healthy lifestyle
against cancer.31 Although this is a good national initiative,
the impact on overall (surgical) cancer care and oncolog-
ical outcome will be limited.
To start with international collaboration between coun-
tries and societies through the WHO, IARC, US National
Cancer Institute Center for Global Health, the Lancet
Global Surgery Commission, GCC, or surgical oncology
societies (e.g. SSO2 and ESSO3) might be the first step on
the way to fighting this cancer burden by way of (i) edu-
cational exchange programs to enhance the curriculum
content of undergraduate, postgraduate, surgical resident,
and fellowship training programs in the basic principles of
surgical oncology and multidisciplinary cancer confer-
ences, as well as virtual training; (ii) the implementation of
eHealth and mHealth technology and education programs
at schools and to the general public, for education in health
behavior, cancer prevention, diagnosis, and (surgical)
cancer treatment; and (iii) simple tricorders for cancer
diagnosis with mHealth technology.
Digital technology is transforming health and social care
in the HICs, but also expanding to LMICs.32 The Depart-
ment of Health and Human Services is providing funding
opportunities through the National Cancer Institute RFA-
CA-15-024 Cancer Detection, Diagnosis, and Treatment
Technologies for Global Health, e.g. LMICs, the UG3/UH3
mechanism.33 Education with eHealth and mHealth tech-
nology, as well as collaboration and support from
community and university-based surgical leaders and sur-
gical oncology societies, is essential to successfully
decrease the global cancer burden. According to Murray
Brennan, ‘Western surgical oncology clinics’ can provide
life-changing experiences for surgical residents to achieve
a better understanding of cancer and the surgical options
for fighting cancer through an educational exchange
instead of a sophisticated fellowship.5
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